StonvexLoading…
StonvexStonvexStonvexCore line items from XOM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 | Annual 2018 2018-12-31 |
|---|---|---|---|---|
Revenue | $276.69B | $178.57B | $255.58B | $279.33B |
Operating Income | $31.23B | $-28.88B | $20.06B | $30.95B |
Net Income | $23.04B | $-22.44B | $14.34B | $20.84B |
EPS (Diluted) | $5.39 | $-5.25 | $3.36 | $4.88 |
Total Assets | $338.92B | $332.75B | $362.60B | $346.20B |
Total Liabilities | $163.24B | $168.62B | $163.66B | $147.67B |
Cash & Equivalents | $6.80B | $4.36B | $3.09B | $3.04B |
Free Cash Flow OCF − CapEx | $36.05B | $-2.61B | $5.36B | $16.44B |
Shares Outstanding | 4.24B | 4.23B | 4.23B | 4.24B |